Nonsteroidal anti-inflammatory drugs sensitize epithelial cells to Clostridioides difficile toxin–mediated mitochondrial damage
Science Advances · 2023
DOI: 10.1126/sciadv.adh5552 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2023. Verfasst von Joshua Soto Ocaña und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Protective Immunity, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA. Hauptthemen laut MEDLINE: Bacterial Toxins, Clostridioides difficile. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIDDK NIH HHS, BLRD VA.
Abstract (Originalsprache)
Clostridioides difficile damages the colonic mucosa through the action of two potent exotoxins. Factors shaping C. difficile pathogenesis are incompletely understood but are likely due to the ecological factors in the gastrointestinal ecosystem, mucosal immune responses, and environmental factors. Little is known about the role of pharmaceutical drugs during C. difficile infection (CDI), but recent studies have demonstrated that nonsteroidal anti-inflammatory drugs (NSAIDs) worsen CDI. The mechanism underlying this phenomenon remains unclear. Here, we show that NSAIDs exacerbate CDI by disrupting colonic epithelial cells (CECs) and sensitizing cells to C. difficile toxin–mediated damage independent of their canonical role of inhibiting cyclooxygenase (COX) enzymes. Notably, we find that NSAIDs and C. difficile toxins target the mitochondria of CECs and enhance C. difficile toxin–mediated damage. Our results demonstrate that NSAIDs exacerbate CDI by synergizing with C. difficile toxins to damage host cell mitochondria. Together, this work highlights a role for NSAIDs in exacerbating microbial infection in the colon.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Protective Immunity, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
- Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
- Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
- Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
- Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
ORCID-Profile: Joshua Soto Ocaña, Jessica L Hart, D Borden Lacy, David M Aronoff, Joseph P Zackular
Förderung
- NIAID NIH HHS
- NIDDK NIH HHS
- BLRD VA
- NIGMS NIH HHS
Zitieren
APA
Soto Ocaña, J., Bayard, N. U., Hart, J. L., Thomas, A. K., Furth, E. E., Lacy, D. B., Aronoff, D. M., & Zackular, J. P. (2023). Nonsteroidal anti-inflammatory drugs sensitize epithelial cells to Clostridioides difficile toxin–mediated mitochondrial damage. Science Advances. https://doi.org/10.1126/sciadv.adh5552
Vancouver
Soto Ocaña J, Bayard NU, Hart JL, Thomas AK, Furth EE, Lacy DB, et al. Nonsteroidal anti-inflammatory drugs sensitize epithelial cells to Clostridioides difficile toxin–mediated mitochondrial damage. Science Advances. 2023. doi:10.1126/sciadv.adh5552
BibTeX
@article{SotoOcaa2023,
author = {Soto Ocaña, Joshua and Bayard, Nile U and Hart, Jessica L and Thomas, Audrey K and Furth, Emma E and Lacy, D Borden and Aronoff, David M and Zackular, Joseph P},
title = {Nonsteroidal anti-inflammatory drugs sensitize epithelial cells to Clostridioides difficile toxin–mediated mitochondrial damage},
journal = {Science Advances},
year = {2023},
doi = {10.1126/sciadv.adh5552}
}
EUVIMED